A compound of Formula wherein R 1 is selected from the group consisting of C 1-4 alkyl, C 1-4 alkoxy, 2,2-difluoroethoxy, di(C 1-4 alkyl)amino, trifluoromethoxy, fluoro, and trifluoromethyl; R 2 is hydrogen; or, R 2 may be taken with R 1 and the phenyl ring to which R 1 and R 2 are both attached to form 2,3-dihydrobenzofuran-7-yl or 1,3-benzodioxol-4-yl; R 3 is hydrogen, methyl, methoxy, chloro, or fluoro; Q is selected from the group consisting of Q1, Q2, and Q3; wherein R 4 is selected from the group consisting of hydrogen, C 1-4 alkyl, C 1-4 alkoxy, cyano, fluoro, and chloro; R 5 is independently selected from the group consisting of hydrogen, C 1-4 alkyl, C 1-4 alkoxy, cyano, chloro, and di(C 1-4 alkyl)amino; G is selected from the group consisting of 4-methylphenyl, 3-cyanophenyl, 4-cyanophenyl, 4-methoxycarbonylphenyl, 2-chloro-quinolin-6-yl, morpholin-4-ylsulfonyl, morpholin-4-yl(C 1-4 alkyl)aminosulfonyl, 2,6-dimethylmorpholin-4-ylsulfonyl,C 6 - 10 aryl(C 1-4)alkylsulfonyl, C 6-10 aryloxy(C 1-4)alkylsulfonyl, 3,5-dimethylisoxazol-4-yl-sulfonyl,, C 1-4 alkoxycarbonyl(C 1-4)alkyl-sulfonyl,, trifluoromethylsulfonyl, C 3-7 cycloalkylsulfonyl, 2,2,2-trifluoroethylsulfonyl, di(C 1-4 alkyl)aminosulfonyl, di(C 1-4 alkyl)aminosulfonylamino(C 1-4)alkyl-sulfonyl, C 1-4 alkylsulfonylamino(C 1-4)alkyl-sulfonyl, 2,5-dione-pyrrolidin-1-yl-(C 1-4)alkyl-sulfonyl, - 1,3-dione-1H-isoindol-1-yl-(C 1-4)alkyl-sulfonyl, 1,1-dioxidotetrahydrothiophen-3-yl)sulfonyl, C 1-6 alkylsulfonyl, di(C 1-4 alkyl)aminosulfonyl, pyrrolidin-1-ylsulfonyl, piperidin-1-ylsulfonyl, 4-(R 6)-piperidin-1-ylsulfonyl wherein R 6 is C 1-4 alkoxycarbonyl or C 1-4 alkyl; azepan-1-ylsulfonyl, methoxymethylcarbonyl, trifluoromethylcarbonyl, C 1-4 alkoxycarbonylamino(C 2-4)alkyl-carbonyl, C 1-4 alkoxycarbonylaminomethyl-carbonyl, trifluoromethylsulfonylaminomethylcarbonyl, trifluoromethoxycarbonyl, C 1-4 alkylsulfonylaminomethyl-carbonyl, C 1-4 alkoxycarbonyl, di(C 1-4 alkyl)aminocarbonyl, C 1-4 alkoxycarbonyl, pyridinylcarbonyl, furanylcarbonyl, and 5-methylisoxazol-3-ylcarbonyl; and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof. R 1 is selected from the group consisting of C 1-4 alkyl, C 1-4 alkoxy, 2,2-difluoroethoxy, di(C 1-4 alkyl)amino, trifluoromethoxy, fluoro, and trifluoromethyl; R 2 is hydrogen; or, R 2 may be taken with R 1 and the phenyl ring to which R 1 and R 2 are both attached to form 2,3-dihydrobenzofuran-7-yl or 1,3-benzodioxol-4-yl; R 3 is hydrogen, methyl, methoxy, chloro, or fluoro; Q is selected from the group consisting of Q1, Q2, and Q3; wherein R 4 is selected from the group consisting of hydrogen, C 1-4 alkyl, C 1-4 alkoxy, cyano, fluoro, and chloro; R 5 is independently selected from the group consisting of hydrogen, C 1-4 alkyl, C 1-4 alkoxy, cyano, chloro, and di(C 1-4 alkyl)amino; R 4 is selected from the group consisting of hydrogen, C 1-4 alkyl, C 1-4 alkoxy, cyano, fluoro, and chloro; R 5 is independently selected from the group consisting of hydrogen, C 1-4 alkyl, C 1-4 alkoxy, cyano, chloro, and di(C 1-4 alkyl)amino; G is selected from the group consisting of 4-methylphenyl, 3-cyanophenyl, 4-cyanophenyl, 4-methoxycarbonylphenyl, 2-chloro-quinolin-6-yl, morpholin-4-ylsulfonyl, morpholin-4-yl(C 1-4 alkyl)aminosulfonyl, 2,6-dimethylmorpholin-4-ylsulfonyl,C 6 - 10 aryl(C 1-4)alkylsulfonyl, C 6-10 aryloxy(C 1-4)alkylsulfonyl, 3,5-dimethylisoxazol-4-yl-sulfonyl,, C 1-4 alkoxycarbonyl(C 1-4)alkyl-sulfonyl,, trifluoromethylsulfonyl, C 3-7 cycloalkylsulfonyl, 2,2,2-trifluoroethylsulfonyl, di(C 1-4 alkyl)aminosulfonyl, di(C 1-4 alkyl)aminosulfonylamino(C 1-4)alkyl-sulfonyl, C 1-4 alkylsulfonylamino(C 1-4)alkyl-sulfonyl, 2,5-dione-pyrrolidin-1-yl-(C 1-4)alkyl-sulfonyl, - 1,3-dione-1H-isoindol-1-yl-(C 1-4)alkyl-sulfonyl, 1,1-dioxidotetrahydrothiophen-3-yl)sulfonyl, C 1-6 alkylsulfonyl, di(C 1-4 alkyl)aminosulfonyl, pyrrolidin-1-ylsulfonyl, piperidin-1-ylsulfonyl, 4-(R 6)-piperidin-1-ylsulfonyl wherein R 6 is C 1-4 alkoxycarbonyl or C 1-4 alkyl; azepan-1-ylsulfonyl, methoxymethylcarbonyl, trifluoromethylcarbonyl, C 1-4 alkoxycarbonylamino(C 2-4)alkyl-carbonyl, C 1-4 alkoxycarbonylaminomethyl-carbonyl, trifluoromethylsulfonylaminomethylcarbonyl, trifluoromethoxycarbonyl, C 1-4 alkylsulfonylaminomethyl-carbonyl, C 1-4 alkoxycarbonyl, di(C 1-4 alkyl)aminocarbonyl, C 1-4 alkoxycarbonyl, pyridinylcarbonyl, furanylcarbonyl, and 5-methylisoxazol-3-ylcarbonyl; and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof.